Lipid-based Polyene Antifungal [EPC]

14500 reported adverse events

Drugs of this class: AMPHOTERICIN B AMPHOTERICIN B, DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- AND DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-

These side effects are most commonly reported by patients taking drugs of the Lipid-based Polyene Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 2965
1 OFF LABEL USE 1413
2 PYREXIA 871
3 CONDITION AGGRAVATED 600
4 FEBRILE NEUTROPENIA 550
5 SEPSIS 540
6 PNEUMONIA 498
7 HYPOKALAEMIA 483
8 ACUTE KIDNEY INJURY 465
9 DEATH 438
See all common reactions for Lipid-based Polyene Antifungal [EPC]

Drugs of the Lipid-based Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOROIDITIS 71 0.2305
1 FUNGAL ENDOCARDITIS 42 0.1900
2 CEREBRAL ASPERGILLOSIS 81 0.1620
3 TRICHOSPORON INFECTION 52 0.1548
4 DISSEMINATED ASPERGILLOSIS 44 0.1481
5 FUSARIUM INFECTION 69 0.1345
6 SCEDOSPORIUM INFECTION 56 0.1159
7 MUCORMYCOSIS 218 0.1054
8 MENINGITIS CRYPTOCOCCAL 122 0.0917
9 SYSTEMIC MYCOSIS 78 0.0879
See all enriched reactions for Lipid-based Polyene Antifungal [EPC]